Pharmaceutical Products Research, Alcon Research, Ltd, Fort Worth, Texas 76134, USA.
J Ocul Pharmacol Ther. 2010 Feb;26(1):21-9. doi: 10.1089/jop.2009.0102.
Immortalized human corneal epithelial (CEPI-17-CL4) cells were exposed to different concentrations of platelet-activating factor (PAF) and the mobilization of intracellular calcium (Ca(2+)) was studied using fluorometrics. Additionally, the production of the cytokines [interleukin-6 (IL-6), interleukin-8 (IL-8), granulocyte macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF-alpha)], and matrix metalloproteinase-1 (MMP-1) and prostaglandin E(2) (PGE(2)) from PAF-stimulated cells was also determined using ELISA assays.
While PAF, histamine, and bradykinin stimulated the mobilization of Ca(2+) in these cells, PAF was the least efficacious. Ca(2+) mobilization induced by PAF was inhibited by 2 PAF receptor antagonists, PCA-42481 and CV-6209 (both 10 microM), and by a phospholipase C inhibitor, U73122 (60% at 4 microM). PAF increased the production of PGE(2) (with maximum effect at 30 and 100 nM) and GM-CSF (maximum effect at 1 microM) in CEPI-17-CL4 cells. However, PAF did not stimulate the generation of IL-6, IL-8, TNF-alpha, and MMP-1 to any significant level and in a consistent manner. PAF increased the incorporation of [(3)H]-thymidine into CEPI-17-CL4 cells with a maximal effect at 30 nM.
These data indicate that functional PAF receptors are present on CEPI-17-CL4 cells that can activate mobilization of Ca(2+). Other consequences of PAF receptor activation in CEPI-17-CL4 cells are the generation of PGE(2) and certain proinflammatory cytokines such as GM-CSF, and increasing cell proliferation.
将永生化人角膜上皮(CEPI-17-CL4)细胞暴露于不同浓度的血小板激活因子(PAF),并使用荧光法研究细胞内钙(Ca(2+))的动员情况。此外,还使用 ELISA 测定试剂盒测定 PAF 刺激细胞产生的细胞因子[白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、粒细胞巨噬细胞集落刺激因子(GM-CSF)和肿瘤坏死因子-α(TNF-α)]和基质金属蛋白酶-1(MMP-1)和前列腺素 E(2)(PGE(2))的产量。
虽然 PAF、组胺和缓激肽刺激这些细胞中Ca(2+)的动员,但 PAF 的作用效果最低。PAF 诱导的Ca(2+)动员被 2 种 PAF 受体拮抗剂 PCA-42481 和 CV-6209(均为 10 microM)以及磷脂酶 C 抑制剂 U73122(4 microM 时抑制 60%)抑制。PAF 增加了 CEPI-17-CL4 细胞中 PGE(2)(在 30 和 100 nM 时达到最大效应)和 GM-CSF(在 1 microM 时达到最大效应)的产生。然而,PAF 并没有以一致的方式刺激 IL-6、IL-8、TNF-α和 MMP-1 的生成达到任何显著水平。PAF 以 30 nM 时最大效应增加 CEPI-17-CL4 细胞中[3H]-胸苷的掺入。
这些数据表明,功能性 PAF 受体存在于 CEPI-17-CL4 细胞中,可激活Ca(2+)的动员。CEPI-17-CL4 细胞中 PAF 受体激活的其他后果是生成 PGE(2)和某些前炎症细胞因子,如 GM-CSF,并增加细胞增殖。